Induction and Prevention of Colonie Inflammation in IL-2-Deficient Mice

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 566-573

  Ehrhardt, Rolf O ^a,c   Lúdvíksson, Björn R ^a   Gray, Belinda ^a   Neurath, Markus ^b   Strober, Warren ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c LCI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HAPTEN; HEMOCYANIN; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; NITROBENZENE DERIVATIVE; OVALBUMIN; THYMUS INDEPENDENT ANTIGEN; TRINITROPHENYL KEYHOLE LIMPET HEMOCYANIN; TRINITROPHENYL OVALBUMIN; TRINITROPHENYL-OVALBUMIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COLITIS; GENETICS; IMMUNIZATION; IMMUNOLOGY; IMMUNOPHENOTYPING; INTESTINE MUCOSA; METABOLISM; MOUSE; MOUSE MUTANT; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, T-INDEPENDENT; COLITIS; HAPTENS; HEMOCYANIN; IMMUNIZATION; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTAGENESIS, SITE-DIRECTED; OVALBUMIN; T-LYMPHOCYTES; TRINITROBENZENES;

EID: 0031568001     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Pirzer, U., A. Schönhaar, B. Heischer, E. Hermann, and K. H. Meyer zum Büschenfelde. 1991. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 338:1238.
2. Sartor, R. B. 1991. Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease. Immunol. Res. 10:465.
3. Pullman, W. E., S. Elsbury, M. Kobayashi, A. J. Hapel. and W. F. Doe. 1992. Enhanced mucosal cytokine production in inflammatory bowel disease. Gasiroenterology 102:529.
4. Breese, E., C. P. Braegger, C. J. Corrigan, J. A. Walker-Smith, and T. T. MacDonald. 1993. Interleukin-2-and interferon-γ-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78:127.
5. + T cells. Immunity 1:553.
6. Kühn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
7. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
8. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:274.
9. Rudolph, U., M. J. Finegold, S. S. Rich, G. R. Harriman, Y. Srinivasan, G. Brabet, P. Boulay, A. Bradley, and L. Birnbaumer. 1995. Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice. Nat. Genet. 10:143.
10. Smith, K. A. 1992. Interleukin-2. Curr. Opin. Immunol. 4:271.
11. Schorle, H., T. Holtschke, T. Hünig, T. A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621.
12. Kundig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262:1059.
13. Ma, A., M. Datta, E. Margosian, J. Chen, and I. Horak. 1995. T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. 7. Exp. Med. 182:1567.
14. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
15. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P. S. Ohashi, H. Griesser, T. Taniguchi, C. Y. Paige, and T. W. Mak. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β Science 268:1472.
16. Seder, R. A., R. N. Germain, P. S. Linsley, and W. E. Paul. 1994. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon γ production. J. Exp. Med. 179:299.
17. Corry, D. B., S. L. Reiner, P. S. Linsley, and R. M. Locksley. 1994. Differential effects of blockade of CD2S-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153:4142.
18. Heinzel, F. P., R. M. Rerko, F. Hatam, and R. M. Locksley. 1993. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J. Immunol. 150:3924.
19. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34.
20. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381.
21. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Rocken. 1994. Cytofcine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
22. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281.
23. Manetti, R., P. Parronchi, M. G. Giodizi, M. P. Piccini, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
24. + T cells. Eur. J. Immunal. 25:3053.
25. Harlan, Y. M., and D. Y. Liu. 1992. Adhesion: Its Role in Inflammatory Disease. W. M. Freeman and Co., New York, pp. 154.
26. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
27. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl Acad. Sci. USA 90:10188.
28. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R. M. Hewich, K. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chaw, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074.
29. Ben-Sasson, S. Z., G. le Gros, D. H. Conrad, F. D. Finkelman, and W. E. Paul. 1990. 1L-4 production by T cells from naive donors. IL-2 is required for IL-4 production. J. Immunol. 145:1127.
30. le Gros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. N. Engl. J. Med. 172:921.
31. Hjulstrom, S., A. Landin, L. Jansson, and B. Holmdahl. 1995. No role of interleukin-4 in CD23/IgE-mediated enhancement of the murine antibody response in vivo. Eur. J. Immunol. 25:1469.
32. von der Weid, T., G. Kopf, and J. Langhorne. 1994. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur. J. Immunol. 24:2285.
33. Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, and K. M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665.
34. Tanaka, T., J. Hu-Li, R. A. Seder, B. F. St. de Groth, and W. E. Paul. 1993. Inlerleukin 4 suppresses interleukin 2 and interferon γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Natl. Acad. Sci USA 90:5914.
35. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
36. de Waal Malefyt, R., C. G. Figdor, and J. E. de Vries. 1993. Effects of interleukin 4 on monocyte functions: comparison to interleukin 13. Res. Immunol. 144:629.
37. Weiner, H. L., A. Friedman, A. Miller, S. J. Khoury, A. al-Sabbagh, L. Santos, M. Sayegh, R. B. Nussenblatt, D. E. Trentham, and D. A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809.
38. Critchfield, J. M., M. K. Racke, J. C. Zuniga-Pflucker, B. Cannella, C. S. Raine, J. Goverman, and M. J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139.
39. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
40. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.
41. Matsuura, T., G. A. West, K. R. Youngman, J. S. Klein, and C. Fiocchi. 1993. Immune activation genes in inflammatory bowel disease. Gastroenterology 104:448.
42. + T cells in inflammatory bowel disease. Gastroenterology 101:1594.
43. Karttunnen, R., E. J. Breese, J. A. Walker-Smith, and T. T. MacDonald. 1994. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation. J. Clin. Pathol. 47:1015.
44. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157:1261.